Royal Bank of Canada’s YD Bio Ltd YDES Stock Holding History

Royal Bank of Canada’s Portfolio YDES Stock Details YDES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+117	New	+$523	﹤0.01%	8000

Other funds holding YDES

GWAG

Garrett Wealth Advisory Group Weatherford, Texas $651M AUM 23.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada's YDES Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in YD Bio Ltd (YDES) in Q2 2026: 117 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #8000 among its holdings.

12 funds tracked by Wall St. Rank hold YDES as of Q2 2026.

Royal Bank of Canada held 117 shares of YD Bio Ltd worth $0 as of Q2 2026.
YD Bio Ltd was a new Royal Bank of Canada position in Q2 2026.
YD Bio Ltd made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #8000 holding.
12 funds tracked by Wall St. Rank held YD Bio Ltd as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.